Globe Life Inc. $GL Shares Sold by Geode Capital Management LLC

Geode Capital Management LLC reduced its holdings in shares of Globe Life Inc. (NYSE:GL) by 0.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,709,102 shares of the company’s stock after selling 12,578 shares during the quarter. Geode Capital Management LLC’s holdings in Globe Life were worth $378,383,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Transcend Capital Advisors LLC boosted its position in shares of Globe Life by 3.9% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock worth $317,000 after acquiring an additional 84 shares in the last quarter. Natural Investments LLC boosted its position in shares of Globe Life by 2.6% in the 4th quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after purchasing an additional 87 shares during the period. Laird Norton Wetherby Wealth Management LLC boosted its position in shares of Globe Life by 2.2% in the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock valued at $646,000 after purchasing an additional 99 shares during the period. Clearstead Advisors LLC boosted its position in shares of Globe Life by 1.9% in the 3rd quarter. Clearstead Advisors LLC now owns 5,273 shares of the company’s stock valued at $754,000 after purchasing an additional 100 shares during the period. Finally, Journey Strategic Wealth LLC boosted its position in shares of Globe Life by 5.0% in the 3rd quarter. Journey Strategic Wealth LLC now owns 2,103 shares of the company’s stock valued at $301,000 after purchasing an additional 101 shares during the period. 81.61% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on GL shares. JPMorgan Chase & Co. upped their target price on Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Texas Capital raised Globe Life to a “strong-buy” rating in a research report on Wednesday, March 18th. Evercore set a $157.00 target price on Globe Life in a research report on Wednesday, February 18th. Wells Fargo & Company upped their target price on Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a research report on Friday, April 10th. Finally, Truist Financial upped their target price on Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 24th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $174.11.

Insider Buying and Selling

In other Globe Life news, CEO Frank M. Svoboda sold 20,000 shares of the stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the completion of the sale, the chief executive officer directly owned 54,020 shares of the company’s stock, valued at approximately $8,463,853.60. This trade represents a 27.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO James Matthew Darden sold 4,663 shares of the stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an average price of $153.88, for a total value of $717,542.44. Following the sale, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at $8,994,439.88. The trade was a 7.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 124,247 shares of company stock valued at $19,040,392 over the last 90 days. Insiders own 2.11% of the company’s stock.

Globe Life Stock Up 0.1%

Globe Life stock opened at $153.46 on Monday. Globe Life Inc. has a twelve month low of $116.73 and a twelve month high of $157.92. The stock has a 50 day moving average of $148.85 and a two-hundred day moving average of $142.77. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $11.91 billion, a price-to-earnings ratio of 10.61 and a beta of 0.49.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The company had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the previous year, the business posted $3.07 earnings per share. The firm’s revenue was up 5.3% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, research analysts expect that Globe Life Inc. will post 15.62 earnings per share for the current year.

Globe Life Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is presently 9.13%.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.